EMILIO
GIL MARTIN
TITULAR DE UNIVERSIDADE - TEMPO COMPLETO
Universidad Camilo José Cela
Villanueva de la Cañada, EspañaPublicacións en colaboración con investigadores/as de Universidad Camilo José Cela (9)
2023
-
Melatonin as Modulator for Sulfur and Nitrogen Mustard-Induced Inflammation, Oxidative Stress and DNA Damage: Molecular Therapeutics
Antioxidants, Vol. 12, Núm. 2
-
POTENTIAL OF MELATONIN TO REVERSE EPIGENETIC ABERRATIONS IN ORAL CANCER: NEW FINDINGS
EXCLI Journal, Vol. 22, pp. 1280-1310
-
Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review
Pharmaceutics, Vol. 15, Núm. 6
2022
-
Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?
Cellular and Molecular Neurobiology, Vol. 42, Núm. 3, pp. 489-500
2021
-
The coronavirus disease 2019 (Covid-19): Key emphasis on melatonin safety and therapeutic efficacy
Antioxidants, Vol. 10, Núm. 7
-
Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option?
DISEASES, Vol. 9, Núm. 2
2020
-
Understanding the oncostatic actions displayed by melatonin in colorectal cancer therapy
Future Medicinal Chemistry, Vol. 12, Núm. 13, pp. 1201-1204
2019
-
Potential of melatonin as adjuvant therapy of oral cancer in the era of epigenomics
Cancers, Vol. 11, Núm. 11
2018
-
Melatonin: A hypothesis for Kawasaki disease treatment
Medical Hypotheses, Vol. 119, pp. 6-10